3 ·Filed Oct 23, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
This is a standard Form 3 filing for a new insider. No trading signal. Monitor for any subsequent Form 4 filings that would indicate open-market buying or selling.
Price Chart
Loading chart...
Executive Summary
Grant Froese filed a Form 3 initial statement of beneficial ownership, reporting 161,263 common shares (held by spouse and a controlled corporation) and 19,737 warrants exercisable at $17.37. This is a routine insider filing with no material financial impact.
Key Facts
- Grant Froese filed Form 3 as a new reporting owner of Helus Pharma Inc.
- Reports 5,263 common shares held by spouse and 156,000 common shares held by Greywolf Management Services Inc.
- Reports 19,737 warrants exercisable at $17.37 per share, expiring August 20, 2030.
- Warrants converted from Canadian exercise price of C$24.32 using exchange rate of C$1.4 = US$1.00.
- Filing date: October 23, 2026; period of report: October 13, 2026.
Financial Impact
No financial impact — routine initial ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000912282-26-001385 |
| Document: 0000912282-26-001385-index.html | 0000912282-26-001385 |
| Document: 0000912282-26-001385.txt | 0000912282-26-001385 |
36 reports for HELP
50% Hit rate @ T+20 Went positive at some point 2 of 4 best @ T+20▲ +45.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 3 | $10.11 | awaiting T+20 | — | $10.36 (+2.47%) |
Oct 26, 2026 today | 3 | $10.86 | awaiting T+20 | — | $10.36 (−4.56%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 21, 2026 5d ago | 6-K | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 15, 2026 11d ago | 6-K | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 15, 2026 11d ago | Press Release | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 8, 2026 18d ago | 6-K | $10.72 | awaiting T+20 | — | $10.36 (−3.36%) |
Showing 10 of 36
US Market Status
Market Closed — Opens Tue (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers